a public good project by the
Synthesis
Company
of California

© 2026

Andrew Pierce | doi.page

0 works0 citations0 h-index

Andrew Pierce

Bangor University(GB)

Publications by Year

Research Areas

Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, RNA modifications and cancer, Myeloproliferative Neoplasms: Diagnosis and Treatment

Most-Cited Works

→ Hypoxia-Induced Down-regulation of BRCA1 Expression by E2Fs(2005)333 cited
→ Eight-channel iTRAQ Enables Comparison of the Activity of Six Leukemogenic Tyrosine Kinases(2007)256 cited
→ Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells(2016)225 cited
→ Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.(1995)216 cited
→ Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells(2006)170 cited
→ Quantitative Proteomic Analysis Using Isobaric Protein Tags Enables Rapid Comparison of Changes in Transcript and Protein Levels in Transformed Cells(2005)108 cited

→ Molecular cloning of the major cell surface heparan sulfate proteoglycan from rat liver.(1992)

99 cited

→ The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors(2014)89 cited

→ Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1(2003)69 cited

→ A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation(2006)67 cited